Merck, Pfizer drug combo extends kidney cancer survival: Study
Merck released interim data from the trial, saying the combination reduced the risk of death by 47 per cent compared with Sutent
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.